NCT01445691 - More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery | Biotech Hunter

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Benign Neoplasms, BrainBrain CancerBrain Neoplasms, BenignBrain Neoplasms, MalignantBrain Tumor, PrimaryBrain Tumor, RecurrentBrain TumorsIntracranial NeoplasmsNeoplasms, BrainNeoplasms, IntracranialPrimary Brain NeoplasmsPrimary Malignant Brain NeoplasmsPrimary Malignant Brain TumorsGliomasGlioblastoma

Interventions

DRUG

5-ALA (Gliolan)

20 mg/kg administered once 3-5 hours prior to surgery

Trial Locations (6)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health System, Detroit

63110

Washington University School of Medicine, St Louis